Want to see TOVX full AI Analyst Report?
Theriva Biologics (TOVX) Income Statement
Theriva Biologics Income Statement
Last quarter (Q2 2026), Theriva Biologics's total revenue was $0.00. In Q2, Theriva Biologics's net income was $-3.22M. See Theriva Biologics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -108.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 14.91M | $ 26.35M | $ 21.43M | $ 21.58M | $ 14.27M | |
| Depreciation and Amortization | $ 108.00K | $ 137.00K | $ 135.00K | $ 85.00K | $ 87.00K |
| $ -23.63M | $ -19.29M | $ -21.96M | $ -19.20M | $ -14.18M | |
| $ -15.02M | $ -26.35M | $ -21.43M | $ -21.58M | $ -14.27M | |
| $ -8.72M | $ 693.00K | $ 1.44M | $ 471.00K | $ 6.00K | |
| $ -23.74M | $ -25.65M | $ -19.99M | $ -21.11M | $ -14.27M | |
| $ -25.25M | $ -25.65M | $ -18.35M | $ -19.68M | $ -14.27M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.08 | $ -19.03 | $ -28.49 | $ -32.66 | $ -1.90 |
| Diluted EPS | $ -2.08 | $ -19.03 | $ -28.48 | $ -32.66 | $ -1.90 |
| Weighted Average Shares Outstanding | 12.14M | 1.35M | 644.00K | 613.09K | 12.19M |
| Weighted Average Shares Outstanding (Diluted) | 12.14M | 1.35M | 644.28K | 613.09K | 12.19M |
Currency in USD
